Christopher Lynch

Christopher Lynch, Ph.D., currently serves as Director of Technology Licensing & Collaborations at AbbVie, a position held since June 2006, where responsibilities include negotiating various collaboration agreements and technology feasibility studies across multiple fields, including immunology and neuroscience. Previously, Christopher held roles at Abbott as Chemistry Group Leader and Research Investigator, focusing on nicotinic agonists in neuroscience and proapoptotic agents in oncology, respectively. Prior to Abbott, Christopher worked at Merck as a Research Fellow in virology and immunology. Christopher holds a Bachelor of Science in Biochemistry from the University of Wisconsin-Madison, an MBA from Cardinal Stritch University, a Ph.D. in Organic Chemistry from the University of Wisconsin-Madison, and completed postdoctoral research at The University of Texas at Austin.